Clinical Scorecard: Exchange of Type I to Type II Boston Keratoprosthesis: A Case Study of Two Patients

At a Glance

Key Highlights

• Type I BKPro is first-line for patients with multiple failed corneal grafts.
• Type II BKPro is designed for patients with severe ocular surface disease.
• Long-term complications of Type I BKPro may necessitate transition to Type II.
• Two case studies demonstrate the feasibility of BKPro exchange.

Guideline-Based Recommendations

Diagnosis

• Evaluate patients with severe corneal blindness for BKPro candidacy.

Management

• Consider Type I BKPro for patients with multiple failed grafts.
• Use Type II BKPro for patients with severe ocular surface disease.

Monitoring & Follow-up

• Regular follow-up for complications such as corneal melting and device extrusion.

Risks

• Potential for infection, device extrusion, and corneal melting.

Patient & Prescribing Data

Patients with severe ocular surface disease and history of failed corneal grafts.

Immunosuppression may be necessary postoperatively; monitor for complications.

Clinical Best Practices

• Initiate immunosuppressive therapy pre- and post-operatively as indicated.
• Perform regular assessments of visual acuity and intraocular pressure.

Related Resources & Content

• Boston Keratoprosthesis Overview